Your browser doesn't support javascript.
loading
Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023.
Bolluyt, Dita C; Euser, Sjoerd M; Souverein, Dennis; van Rossum, Annemarie Mc; Kalpoe, Jayant; van Westreenen, Mireille; Goeijenbier, Marco; Snijders, Dominic; Eggink, Dirk; Jongenotter, Femke; van Lelyveld, Steven Fl; van Houten, Marlies A.
Affiliation
  • Bolluyt DC; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.
  • Euser SM; These authors contributed equally to this work and share authorship.
  • Souverein D; Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands.
  • van Rossum AM; These authors contributed equally to this work and share authorship.
  • Kalpoe J; Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands.
  • van Westreenen M; Department of Paediatrics, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
  • Goeijenbier M; Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands.
  • Snijders D; Department of Medical Microbiology, Erasmus MC University Medical centre, Rotterdam, the Netherlands.
  • Eggink D; Department of Intensive Care Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.
  • Jongenotter F; Department of Intensive Care Medicine, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
  • van Lelyveld SF; Department of Pulmonary Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.
  • van Houten MA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Euro Surveill ; 29(4)2024 Jan.
Article in En | MEDLINE | ID: mdl-38275014
ABSTRACT
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Mycoplasma Type of study: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: Europa Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Mycoplasma Type of study: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: Europa Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: